RadNet Q3 Earnings Call Highlights
RadNet reported Q3 Digital Health revenue up 33% to $32.9M, with adjusted EBITDA at $3M. The segment closed $71M in contracts, including a $53M long-term deal. Annual recurring revenue grew 67% to $112.6M. RadNet raised 2026 imaging revenue guidance to $2.385B-$2.435B and adjusted EBITDA to $350M-$363M. It plans to acquire ONRAD for $350M in cash and 5M shares, expecting $190M-$200M in first-year revenue.
How this was made

The 30-second read
Why it matters
The combined guidance raise and strategic acquisition provide a clear catalyst for short‑term price appreciation, though integration risk remains.
Market read
Earnings beat and acquisition news are material for investors in healthcare and digital health sectors.
What to watch
Potential Medicare reimbursement cuts of $5M and integration earn‑out uncertainty could temper upside.
Background
RadNet reported Q3 results, highlighted digital health growth, and announced a $350M cash‑plus‑stock acquisition of ONRAD.
Ticker impact
Q3 earnings disclosed revenue, EBITDA, raised guidance and announced $350M cash + stock acquisition of ONRAD.
likely upward pressure as investors price in higher revenue outlook and expansion via ONRAD.
Guidance increased by $15M at both ends and a sizable acquisition indicates stronger future cash flow, which typically supports the stock.
Market effects
Radiology and digital health firms may see valuation uplift as the sector gains visibility from RadNet's expansion.
U.S. outpatient imaging market could experience modest consolidation pressure.
Limited to U.S. healthcare investors; no immediate global macro effect.
Counterpoint
The acquisition cost may strain cash flow if integration challenges arise, potentially weighing on the stock.
Key entities
- companyRadNet, Inc.
U.S. outpatient diagnostic imaging provider.
- companyONRAD
Radiology professional services firm being acquired.


